FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310342538> ?p ?o ?g. }

• W4310342538 endingPage "1478" @default.
• W4310342538 startingPage "1449" @default.
• W4310342538 abstract "FMS-like tyrosine kinase 3 (FLT3) is mutated in approximately 30% of acute myeloid leukemia (AML) patients. The presence of FLT3-ITD (internal tandem duplication, 20-25%) mutation and, to a lesser extent, FLT3-TKD (tyrosine kinase domain, 5-10%) mutation is associated with poorer diagnosis and therapy response since the leukemic cells become hyperproliferative and resistant to apoptosis after continuous activation of FLT3 signaling. Targeting FLT3 has been the focus of many pre-clinical and clinical studies. Hence, many small-molecule FLT3 inhibitors (FLT3is) have been developed, some of which are approved such as midostaurin and gilteritinib to be used in different clinical settings, either in combination with chemotherapy or alone. However, many questions regarding the best treatment strategy remain to be answered. On the other hand, various FLT3-dependent and -independent resistance mechanisms could be evolved during FLT3i therapy which limit their clinical impact. Therefore, identifying molecular mechanisms of resistance and developing novel strategies to overcome this obstacle is a current interest in the field. In this review, recent studies of approved FLT3i and knowledge about major resistance mechanisms of clinically approved FLT3i's will be discussed together with novel treatment approaches such as designing novel FLT3i and dual FLT3i and combination strategies including approved FLT3i plus small-molecule agents targeting altered molecules in the resistant cells to abrogate resistance. Moreover, how to choose an appropriate FLT3i for the patients will be summarized based on what is currently known from available clinical data. In addition, strategies beyond FLT3i's including immunotherapeutics, small-molecule FLT3 degraders, and flavonoids will be summarized to highlight potential alternatives in FLT3-mutated AML therapy." @default.
• W4310342538 created "2022-12-09" @default.
• W4310342538 creator A5017604184 @default.
• W4310342538 creator A5064246092 @default.
• W4310342538 date "2022-11-01" @default.
• W4310342538 modified "2023-10-14" @default.
• W4310342538 title "Therapeutic Targeting of FLT3 in Acute Myeloid Leukemia: Current Status and Novel Approaches" @default.
• W4310342538 cites W1211118294 @default.
• W4310342538 cites W1255676896 @default.
• W4310342538 cites W148052780 @default.
• W4310342538 cites W1502007145 @default.
• W4310342538 cites W1521952791 @default.
• W4310342538 cites W1567091232 @default.
• W4310342538 cites W1592701464 @default.
• W4310342538 cites W1662899804 @default.
• W4310342538 cites W1744167954 @default.
• W4310342538 cites W1902764282 @default.
• W4310342538 cites W1905832649 @default.
• W4310342538 cites W1915923979 @default.
• W4310342538 cites W1969366020 @default.
• W4310342538 cites W1984209370 @default.
• W4310342538 cites W1990030298 @default.
• W4310342538 cites W1990870968 @default.
• W4310342538 cites W1990924336 @default.
• W4310342538 cites W1992466036 @default.
• W4310342538 cites W1993300766 @default.
• W4310342538 cites W1994004002 @default.
• W4310342538 cites W1996606746 @default.
• W4310342538 cites W1997412169 @default.
• W4310342538 cites W2000056109 @default.
• W4310342538 cites W2003225492 @default.
• W4310342538 cites W2006301655 @default.
• W4310342538 cites W2010510798 @default.
• W4310342538 cites W2011187792 @default.
• W4310342538 cites W2017107901 @default.
• W4310342538 cites W2017715337 @default.
• W4310342538 cites W2021425093 @default.
• W4310342538 cites W2025678572 @default.
• W4310342538 cites W2028972248 @default.
• W4310342538 cites W2030292335 @default.
• W4310342538 cites W2032235066 @default.
• W4310342538 cites W2034838691 @default.
• W4310342538 cites W2036161897 @default.
• W4310342538 cites W2043216151 @default.
• W4310342538 cites W2044699601 @default.
• W4310342538 cites W2045166052 @default.
• W4310342538 cites W2045587009 @default.
• W4310342538 cites W2047119584 @default.
• W4310342538 cites W2058351564 @default.
• W4310342538 cites W2062006594 @default.
• W4310342538 cites W2062012261 @default.
• W4310342538 cites W2071754840 @default.
• W4310342538 cites W2072404566 @default.
• W4310342538 cites W2073788073 @default.
• W4310342538 cites W2080352180 @default.
• W4310342538 cites W2083221109 @default.
• W4310342538 cites W2085397716 @default.
• W4310342538 cites W2086580946 @default.
• W4310342538 cites W2088071763 @default.
• W4310342538 cites W2097583774 @default.
• W4310342538 cites W2100869656 @default.
• W4310342538 cites W2105434446 @default.
• W4310342538 cites W2107826507 @default.
• W4310342538 cites W2112414163 @default.
• W4310342538 cites W2113230030 @default.
• W4310342538 cites W2117513720 @default.
• W4310342538 cites W2120032851 @default.
• W4310342538 cites W2130864403 @default.
• W4310342538 cites W2136245759 @default.
• W4310342538 cites W2144249142 @default.
• W4310342538 cites W2144830414 @default.
• W4310342538 cites W2150443333 @default.
• W4310342538 cites W2151222524 @default.
• W4310342538 cites W2153345005 @default.
• W4310342538 cites W2154625299 @default.
• W4310342538 cites W2160140526 @default.
• W4310342538 cites W2160950237 @default.
• W4310342538 cites W2166969231 @default.
• W4310342538 cites W2171484579 @default.
• W4310342538 cites W2172116766 @default.
• W4310342538 cites W2191511762 @default.
• W4310342538 cites W2197292765 @default.
• W4310342538 cites W2280729002 @default.
• W4310342538 cites W2285221273 @default.
• W4310342538 cites W2301429255 @default.
• W4310342538 cites W2302152738 @default.
• W4310342538 cites W2302851559 @default.
• W4310342538 cites W2308905752 @default.
• W4310342538 cites W2315415869 @default.
• W4310342538 cites W2397194059 @default.
• W4310342538 cites W2411285133 @default.
• W4310342538 cites W2419140434 @default.
• W4310342538 cites W2431218506 @default.
• W4310342538 cites W2469094794 @default.
• W4310342538 cites W2520109448 @default.
• W4310342538 cites W2536356026 @default.
• W4310342538 cites W2553392785 @default.
• W4310342538 cites W2556330819 @default.

• next